Virtual Reality and Cranial Nerve Neuromodulation to Manage Chronic Pain
Launched by UNIVERSITÉ DE SHERBROOKE · Jul 3, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help veterans who suffer from long-lasting pain and post-traumatic stress disorder (PTSD). Researchers want to see if using virtual reality (VR)—a technology that creates immersive, computer-generated environments—along with a special, non-invasive treatment that gently stimulates nerves on the tongue, can reduce pain and help balance the nervous system. The goal is to find out if combining these two therapies works better than VR alone to improve pain and overall well-being in veterans.
To take part, you need to be a veteran aged 30 or older who has had muscle or joint pain for more than six months and has been diagnosed with PTSD by a doctor or scored high on a PTSD questionnaire. The study will last about 20 minutes per session, during which you will try VR and the tongue stimulation treatment while your pain and nervous system responses are measured before and after. This study is not yet recruiting, and some people won’t be eligible, such as those with certain mental health conditions, nerve pain types, epilepsy, or sensitivity to light or motion. If successful, this research could lead to new, easy-to-use treatments to help veterans better manage chronic pain and PTSD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Be a veteran;
- • 2. Be ≥30 years old;
- • 3. Have a diagnosis of chronic musculoskeletal pain (pain \> 6 months);
- • 4. Have been diagnosed with PTSD by a health professional and/or have a PTSD Checklist for DSM-5 (PCL-5) score \> 30/80 and
- • 5. Speak English or French.
- Exclusion Criteria:
- • 1. Bipolar disorder, psychosis;
- • 2. Neuropathic pain (based on the Neuropathic Pain Diagnosis and Questionnaire (DN4));
- • 3. Visual disorders or photosensitivity, color blindness;
- • 4. Epilepsy, motion sickness and
- • 5. Any containdications to CN-NINM.
About Université De Sherbrooke
The Université de Sherbrooke is a leading research institution in Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. With a focus on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient care. Its research team comprises experienced professionals dedicated to ensuring the highest ethical standards and scientific rigor in clinical research. The Université de Sherbrooke strives to translate research findings into practical solutions that enhance health outcomes and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sherbrooke, Quebec, Canada
Patients applied
Trial Officials
Guillaume Léonard, PhD
Principal Investigator
Université de Sherbrooke
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported